Health News: [cancer]

Amgen to Appeal CHMP Opinion on Vectibix(R) (Panitum. Stock World Wed, 30 Mar 2011 14:01 PM PDT Thousand Oaks, California (ots/PRNewswire) - Amgen announced today that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in March by the Committee For Medicinal Products for Human Use (CHMP) for the use of Vectibix in combination with chemotherapy for patients with wild-type KRAS metastatic colorectal cancer (mCRC). Amgen to Appeal CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in ... wallstreet:online AG Wed, 30 Mar 2011 14:01 PM PDT THOUSAND OAKS, California, March 30, 2011 /PRNewswire/ Amgen announced today that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in March by the Committee For Medicinal … Medicare to pay for $93,000 prostate cancer drug AP via Yahoo! Finance Wed, 30 Mar 2011 13:56 PM PDT Medicare officials said Wednesday that the program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that gives men suffering from the disease an extra four months to live, on average. ME Takes Officer’s Body From Wake In Debate Over Cause Of Death CBS New York Wed, 30 Mar 2011 13:51 PM PDT Officer George Wong, 48, died Thursday after a two-year battle with gastric cancer which was initially determined to have been a result of exposure to 9/11 toxins. Judicial Watch Obtains Records Detailing Medicare/Medicaid Controversial Review of Cancer Treatment Provenge Marketwire via Yahoo! Finance Wed, 30 Mar 2011 13:51 PM PDT WASHINGTON, DC--(Marketwire - 03/30/11) - Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it has obtained documents from the Department of Health and Human Services regarding the controversial review of the prostate cancer treatment Provenge by the Centers for Medicare and Medicaid Services (CMS). Judicial Watch obtained the ... RRG industry leader Donald Breakstone dies Business Insurance Wed, 30 Mar 2011 13:49 PM PDT GLENCOE, Ill.â€"Donald Breakstone, a former chair of the National Risk Retention Assn. and a longtime advocate of the risk retention group industry, has died of cancer. He was 66. Organizers get creative trying to raise funds for Relay for Life The Sand Mountain Reporter Wed, 30 Mar 2011 13:47 PM PDT Relay For Life organizers expect the Purple Pottie to flush donations into the coffers of cancer research. CMS Plans To Pay For Provenge Forbes Wed, 30 Mar 2011 13:46 PM PDT Investors in Dendreon have been waiting eagerly for news about whether the Centers for Medicare and Medicaid Services would pay for the company's prostate cancer treatment Provenge. Protein 'link to cancer return' Press Assoc. via Yahoo! UK & Ireland News Wed, 30 Mar 2011 13:41 PM PDT Two proteins have been identified that appear to play a key role in making women unresponsive to breast cancer treatment. Researchers find possible clues to tamoxifen resistance in breast cancer patients PhysOrg Wed, 30 Mar 2011 13:39 PM PDT Breast cancer patients who become resistant to tamoxifen may have low levels of a protein called Rho GDI-alpha, according to a study published online March 30 in the Journal of the National Cancer Institute.

See more health stories that match my keyword Visit Yahoo! Health

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.